{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:56:50Z","timestamp":1769194610444,"version":"3.49.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,8]]},"DOI":"10.7759\/cureus.89629","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T16:45:18Z","timestamp":1754671518000},"source":"Crossref","is-referenced-by-count":1,"title":["Exploring the Emerging Role of Stem Cell Therapy in Neurodegenerative Diseases and Spinal Cord Injury: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Anvvi","family":"Kademani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos","family":"Avraam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansu","family":"Paloh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nethra","family":"Somannagari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarushi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali W","family":"Lafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alonso  E","family":"Algaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabeeul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheeranthodika","family":"Fahima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humza F","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger BN","year":"2017","unstructured":"Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017, 9:10.1101\/cshperspect.a028035","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(24)00264-X","article-title":"The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territories","volume":"12","author":"Chen S","year":"2024","unstructured":"Chen S, Cao Z, Nandi A, et al.. The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territories. Lancet Glob Health. 2024, 12:1534-1543. 10.1016\/S2214-109X(24)00264-X","journal-title":"Lancet Glob Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1386608","article-title":"The rise of Parkinson's disease is a global challenge, but efforts to tackle this must begin at a national level: a protocol for national digital screening and \"eat, move, sleep\" lifestyle interventions to prevent or slow the rise of non-communicable diseases in Thailand","volume":"15","author":"Bhidayasiri R","year":"2024","unstructured":"Bhidayasiri R, Sringean J, Phumphid S, et al.. The rise of Parkinson's disease is a global challenge, but efforts to tackle this must begin at a national level: a protocol for national digital screening and \"eat, move, sleep\" lifestyle interventions to prevent or slow the rise of non-communicable diseases in Thailand. Front Neurol. 2024, 15:1386608. 10.3389\/fneur.2024.1386608","journal-title":"Front Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207474","article-title":"Global prevalence and incidence of amyotrophic lateral sclerosis: a systematic review","volume":"101","author":"Wolfson C","year":"2023","unstructured":"Wolfson C, Gauvin DE, Ishola F, Oskoui M. Global prevalence and incidence of amyotrophic lateral sclerosis: a systematic review. Neurology. 2023, 101:e613-23. 10.1212\/WNL.0000000000207474","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29228","article-title":"Prevalence and incidence of Huntington's disease: an updated systematic review and meta-analysis","volume":"37","author":"Medina A","year":"2022","unstructured":"Medina A, Mahjoub Y, Shaver L, Pringsheim T. Prevalence and incidence of Huntington's disease: an updated systematic review and meta-analysis. Mov Disord. 2022, 37:2327-35. 10.1002\/mds.29228","journal-title":"Mov Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.18","article-title":"Traumatic spinal cord injury","volume":"3","author":"Ahuja CS","year":"2017","unstructured":"Ahuja CS, Wilson JR, Nori S, et al.. Traumatic spinal cord injury. Nat Rev Dis Primers. 2017, 3:17018. 10.1038\/nrdp.2017.18","journal-title":"Nat Rev Dis Primers"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.02.033","article-title":"Traumatic spinal injury: global epidemiology and worldwide volume","volume":"113","author":"Kumar R","year":"2018","unstructured":"Kumar R, Lim J, Mekary RA, et al.. Traumatic spinal injury: global epidemiology and worldwide volume. World Neurosurg. 2018, 113:e345-63. 10.1016\/j.wneu.2018.02.033","journal-title":"World Neurosurg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S68889","article-title":"Global prevalence and incidence of traumatic spinal cord injury","volume":"6","author":"Singh A","year":"2014","unstructured":"Singh A, Tetreault L, Kalsi-Ryan S, et al.. Global prevalence and incidence of traumatic spinal cord injury. Clin Epidemiol. 2014, 6:309-31. 10.2147\/CLEP.S68889","journal-title":"Clin Epidemiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: translating evidence into policy","volume":"19","author":"Feigin VL","year":"2020","unstructured":"Feigin VL, Vos T, Nichols E, et al.. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020, 19:255-65. 10.1016\/S1474-4422(19)30411-9","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-160798","article-title":"Are stem cell-based therapies for Parkinson's disease ready for the clinic in 2016?","volume":"6","author":"Barker RA","year":"2016","unstructured":"Barker RA, Parmar M, Kirkeby A, et al.. Are stem cell-based therapies for Parkinson's disease ready for the clinic in 2016?. J Parkinsons Dis. 2016, 6:57-63. 10.3233\/JPD-160798","journal-title":"J Parkinsons Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"GBD 2016 Neurology Collaborators","year":"2019","unstructured":"GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019, 18:459-80. 10.1016\/S1474-4422(18)30499-X","journal-title":"Lancet Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3171\/2012.5.AOSPINE12116","article-title":"Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury","volume":"17","author":"Tator CH","year":"2012","unstructured":"Tator CH, Hashimoto R, Raich A, et al.. Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury. J Neurosurg Spine. 2012, 17:157-229. 10.3171\/2012.5.AOSPINE12116","journal-title":"J Neurosurg Spine"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.291","article-title":"Application of stem cells in regeneration medicine","volume":"4","author":"Jin Y","year":"2023","unstructured":"Jin Y, Li S, Yu Q, et al.. Application of stem cells in regeneration medicine. MedComm (2020). 2023, 4:e291. 10.1002\/mco2.291","journal-title":"MedComm (2020)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03885-z","article-title":"Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities","volume":"15","author":"Zhidu S","year":"2024","unstructured":"Zhidu S, Ying T, Rui J, Chao Z. Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities. Stem Cell Res Ther. 2024, 15:266. 10.1186\/s13287-024-03885-z","journal-title":"Stem Cell Res Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093103","article-title":"Neural stem cell transplantation for neurodegenerative diseases","volume":"21","author":"De Gioia R","year":"2020","unstructured":"De Gioia R, Biella F, Citterio G, et al.. Neural stem cell transplantation for neurodegenerative diseases. Int J Mol Sci. 2020, 21:10.3390\/ijms21093103","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01987-1","article-title":"Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives","volume":"29","author":"Rahimi Darehbagh R","year":"2024","unstructured":"Rahimi Darehbagh R, Seyedoshohadaei SA, Ramezani R, Rezaei N. Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives. Eur J Med Res. 2024, 29:386. 10.1186\/s40001-024-01987-1","journal-title":"Eur J Med Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-020-00475-3","article-title":"Treatment of spinal cord injury with mesenchymal stem cells","volume":"10","author":"Liau LL","year":"2020","unstructured":"Liau LL, Looi QH, Chia WC, et al.. Treatment of spinal cord injury with mesenchymal stem cells. Cell Biosci. 2020, 10:112. 10.1186\/s13578-020-00475-3","journal-title":"Cell Biosci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22042153","article-title":"Regenerative stem cell therapy for neurodegenerative diseases: an overview","volume":"22","author":"Sivandzade F","year":"2021","unstructured":"Sivandzade F, Cucullo L. Regenerative stem cell therapy for neurodegenerative diseases: an overview. Int J Mol Sci. 2021, 22:10.3390\/ijms22042153","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/0963689718773363","article-title":"Stem cell therapy: a promising therapeutic method for intracerebral hemorrhage","volume":"27","author":"Gao L","year":"2018","unstructured":"Gao L, Xu W, Li T, et al.. Stem cell therapy: a promising therapeutic method for intracerebral hemorrhage. Cell Transplant. 2018, 27:1809-24. 10.1177\/0963689718773363","journal-title":"Cell Transplant"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.02.017","article-title":"Purification and characterization of human neural stem and progenitor cells","volume":"186","author":"Liu DD","year":"2023","unstructured":"Liu DD, He JQ, Sinha R, et al.. Purification and characterization of human neural stem and progenitor cells. Cell. 2023, 186:1179-1194.e15. 10.1016\/j.cell.2023.02.017","journal-title":"Cell"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/brv.12959","article-title":"Programmed ageing: decline of stem cell renewal, immunosenescence, and Alzheimer's disease","volume":"98","author":"Lathe R","year":"2023","unstructured":"Lathe R, St Clair D. Programmed ageing: decline of stem cell renewal, immunosenescence, and Alzheimer's disease. Biol Rev Camb Philos Soc. 2023, 98:1424-58. 10.1111\/brv.12959","journal-title":"Biol Rev Camb Philos Soc"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147697","article-title":"Characterization of endothelial progenitor cell: past, present, and future","volume":"23","author":"Salybekov AA","year":"2022","unstructured":"Salybekov AA, Kobayashi S, Asahara T. Characterization of endothelial progenitor cell: past, present, and future. Int J Mol Sci. 2022, 23:10.3390\/ijms23147697","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.896531","article-title":"Significance of placental mesenchymal stem cell in placenta development and implications for preeclampsia","volume":"13","author":"Zhang Y","year":"2022","unstructured":"Zhang Y, Zhong Y, Zou L, Liu X. Significance of placental mesenchymal stem cell in placenta development and implications for preeclampsia. Front Pharmacol. 2022, 13:896531. 10.3389\/fphar.2022.896531","journal-title":"Front Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2024.02.011","article-title":"Autofluorescence is a biomarker of neural stem cell activation state","volume":"31","author":"Morrow CS","year":"2024","unstructured":"Morrow CS, Tweed K, Farhadova S, et al.. Autofluorescence is a biomarker of neural stem cell activation state. Cell Stem Cell. 2024, 31:570-581.e7. 10.1016\/j.stem.2024.02.011","journal-title":"Cell Stem Cell"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101680","article-title":"A glia-enriched stem cell 3D model of the human brain mimics the glial-immune neurodegenerative phenotypes of multiple sclerosis","volume":"5","author":"Fagiani F","year":"2024","unstructured":"Fagiani F, Pedrini E, Taverna S, et al.. A glia-enriched stem cell 3D model of the human brain mimics the glial-immune neurodegenerative phenotypes of multiple sclerosis. Cell Rep Med. 2024, 5:101680. 10.1016\/j.xcrm.2024.101680","journal-title":"Cell Rep Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.72195","article-title":"Transcriptional regulation of neural stem cell expansion in the adult hippocampus","volume":"11","author":"Guo N","year":"2022","unstructured":"Guo N, McDermott KD, Shih YT, et al.. Transcriptional regulation of neural stem cell expansion in the adult hippocampus. Elife. 2022, 11:10.7554\/eLife.72195","journal-title":"Elife"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2019.01.005","article-title":"Neural stem cell niche heterogeneity","volume":"95","author":"Andreotti JP","year":"2019","unstructured":"Andreotti JP, Silva WN, Costa AC, et al.. Neural stem cell niche heterogeneity. Semin Cell Dev Biol. 2019, 95:42-53. 10.1016\/j.semcdb.2019.01.005","journal-title":"Semin Cell Dev Biol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2020.101351","article-title":"Umbilical cord stem cells: background, processing and applications","volume":"65","author":"Alatyyat SM","year":"2020","unstructured":"Alatyyat SM, Alasmari HM, Aleid OA, et al.. Umbilical cord stem cells: background, processing and applications. Tissue Cell. 2020, 65:101351. 10.1016\/j.tice.2020.101351","journal-title":"Tissue Cell"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052715","article-title":"Exploring the interplay between bone marrow stem cells and obesity","volume":"25","author":"Moscatelli F","year":"2024","unstructured":"Moscatelli F, Monda A, Messina G, et al.. Exploring the interplay between bone marrow stem cells and obesity. Int J Mol Sci. 2024, 25:10.3390\/ijms25052715","journal-title":"Int J Mol Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11010039","article-title":"The emerging role of menstrual-blood-derived stem cells in endometriosis","volume":"11","author":"Cordeiro MR","year":"2022","unstructured":"Cordeiro MR, Carvalhos CA, Figueiredo-Dias M. The emerging role of menstrual-blood-derived stem cells in endometriosis. Biomedicines. 2022, 11:10.3390\/biomedicines11010039","journal-title":"Biomedicines"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.25122\/jml-2022-0346","article-title":"Differentiation of neurosphere after transplantation into the damaged spinal cord","volume":"16","author":"Gramatiuk SM","year":"2023","unstructured":"Gramatiuk SM, Ivanova YV, Hudyma AA, et al.. Differentiation of neurosphere after transplantation into the damaged spinal cord. J Med Life. 2023, 16:689-98. 10.25122\/jml-2022-0346","journal-title":"J Med Life"},{"key":"ref32","article-title":"Therapeutic application of neural stem cells and adult neurogenesis for neurodegenerative disorders: regeneration and beyond","volume":"1","author":"Latchney SE","year":"2012","unstructured":"Latchney SE, Eisch AJ. Therapeutic application of neural stem cells and adult neurogenesis for neurodegenerative disorders: regeneration and beyond. Eur J Neurodegener Dis. 2012, 1:335-51.","journal-title":"Eur J Neurodegener Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.676621","article-title":"Immune response in neurological pathology: emerging role of central and peripheral immune crosstalk","volume":"12","author":"Passaro AP","year":"2021","unstructured":"Passaro AP, Lebos AL, Yao Y, Stice SL. Immune response in neurological pathology: emerging role of central and peripheral immune crosstalk. Front Immunol. 2021, 12:676621. 10.3389\/fimmu.2021.676621","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X19666210806163352","article-title":"The role of stem cells in the therapy of stroke","volume":"20","author":"Ejma M","year":"2022","unstructured":"Ejma M, Madetko N, Brzecka A, et al.. The role of stem cells in the therapy of stroke. Curr Neuropharmacol. 2022, 20:630-47. 10.2174\/1570159X19666210806163352","journal-title":"Curr Neuropharmacol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/hipo.22405","article-title":"Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss","volume":"25","author":"Ager RR","year":"2015","unstructured":"Ager RR, Davis JL, Agazaryan A, et al.. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss. Hippocampus. 2015, 25:813-26. 10.1002\/hipo.22405","journal-title":"Hippocampus"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123296","article-title":"Neural stem cells: promoting axonal regeneration and spinal cord connectivity","volume":"10","author":"de Freria CM","year":"2021","unstructured":"de Freria CM, Van Niekerk E, Blesch A, Lu P. Neural stem cells: promoting axonal regeneration and spinal cord connectivity. Cells. 2021, 10:10.3390\/cells10123296","journal-title":"Cells"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-023-01344-6","article-title":"The use of stem cells as a potential treatment method for selected neurodegenerative diseases: review","volume":"43","author":"Cecerska-Hery\u0107 E","year":"2023","unstructured":"Cecerska-Hery\u0107 E, P\u0119ka\u0142a M, Serwin N, et al.. The use of stem cells as a potential treatment method for selected neurodegenerative diseases: review. Cell Mol Neurobiol. 2023, 43:2643-73. 10.1007\/s10571-023-01344-6","journal-title":"Cell Mol Neurobiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0468-3","article-title":"Modeling Alzheimer's disease with iPSC-derived brain cells","volume":"25","author":"Penney J","year":"2020","unstructured":"Penney J, Ralvenius WT, Tsai LH. Modeling Alzheimer's disease with iPSC-derived brain cells. Mol Psychiatry. 2020, 25:148-67. 10.1038\/s41380-019-0468-3","journal-title":"Mol Psychiatry"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2015.06.007","article-title":"Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial","volume":"1","author":"Kim HJ","year":"2015","unstructured":"Kim HJ, Seo SW, Chang JW, et al.. Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial. Alzheimers Dement (N Y). 2015, 1:95-102. 10.1016\/j.trci.2015.06.007","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00897-2","article-title":"Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial","volume":"13","author":"Kim HJ","year":"2021","unstructured":"Kim HJ, Cho KR, Jang H, et al.. Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial. Alzheimers Res Ther. 2021, 13:154. 10.1186\/s13195-021-00897-2","journal-title":"Alzheimers Res Ther"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03559-0","article-title":"Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer's disease: a randomized controlled phase 2a trial","volume":"31","author":"Rash BG","year":"2025","unstructured":"Rash BG, Ramdas KN, Agafonova N, et al.. Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer's disease: a randomized controlled phase 2a trial. Nat Med. 2025, 31:1257-66. 10.1038\/s41591-025-03559-0","journal-title":"Nat Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12651","article-title":"Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease","volume":"19","author":"Brody M","year":"2023","unstructured":"Brody M, Agronin M, Herskowitz BJ, et al.. Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease. Alzheimers Dement. 2023, 19:261-73. 10.1002\/alz.12651","journal-title":"Alzheimers Dement"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2020.12.002","article-title":"Transplantation of human dental pulp stem cells compensates for striatal atrophy and modulates neuro-inflammation in 3-nitropropionic acid rat model of Huntington's disease","volume":"170","author":"Eskandari N","year":"2021","unstructured":"Eskandari N, Boroujeni ME, Abdollahifar MA, et al.. Transplantation of human dental pulp stem cells compensates for striatal atrophy and modulates neuro-inflammation in 3-nitropropionic acid rat model of Huntington's disease. Neurosci Res. 2021, 170:133-44. 10.1016\/j.neures.2020.12.002","journal-title":"Neurosci Res"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1186\/scrt341","article-title":"Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6\/2 mice: behavioral and neuropathological analysis","volume":"4","author":"Fink KD","year":"2013","unstructured":"Fink KD, Rossignol J, Crane AT, et al.. Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6\/2 mice: behavioral and neuropathological analysis. Stem Cell Res Ther. 2013, 4:130. 10.1186\/scrt341","journal-title":"Stem Cell Res Ther"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00628","article-title":"Induced pluripotent stem cell-derived neural stem cell transplantations reduced behavioral deficits and ameliorated neuropathological changes in YAC128 mouse model of Huntington's disease","volume":"11","author":"Al-Gharaibeh A","year":"2017","unstructured":"Al-Gharaibeh A, Culver R, Stewart AN, et al.. Induced pluripotent stem cell-derived neural stem cell transplantations reduced behavioral deficits and ameliorated neuropathological changes in YAC128 mouse model of Huntington's disease. Front Neurosci. 2017, 11:628. 10.3389\/fnins.2017.00628","journal-title":"Front Neurosci"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2017.1365133","article-title":"Induced neural stem cells as a means of treatment in Huntington's disease","volume":"17","author":"Choi KA","year":"2017","unstructured":"Choi KA, Hong S. Induced neural stem cells as a means of treatment in Huntington's disease. Expert Opin Biol Ther. 2017, 17:1333-43. 10.1080\/14712598.2017.1365133","journal-title":"Expert Opin Biol Ther"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-160199","article-title":"Induced pluripotent stem cells in\u00a0Huntington's disease research: progress\u00a0and opportunity","volume":"5","author":"Tousley A","year":"2016","unstructured":"Tousley A, Kegel-Gleason KB. Induced pluripotent stem cells in\u00a0Huntington's disease research: progress\u00a0and opportunity. J Huntingtons Dis. 2016, 5:99-131. 10.3233\/JHD-160199","journal-title":"J Huntingtons Dis"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/1109967","article-title":"Mesenchymal stem cell therapy for Huntington disease: a meta-analysis","volume":"2023","author":"Liang XS","year":"2023","unstructured":"Liang XS, Sun ZW, Thomas AM, Li S. Mesenchymal stem cell therapy for Huntington disease: a meta-analysis. Stem Cells Int. 2023, 2023:1109967. 10.1155\/2023\/1109967","journal-title":"Stem Cells Int"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-332921","article-title":"Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson's disease","volume":"95","author":"Jiang S","year":"2024","unstructured":"Jiang S, Wang H, Yang C, et al.. Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2024, 95:1102-11. 10.1136\/jnnp-2023-332921","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.8b00389","article-title":"Progress in dopaminergic cell replacement and regenerative strategies for Parkinson's disease","volume":"10","author":"Chen W","year":"2019","unstructured":"Chen W, Huang Q, Ma S, Li M. Progress in dopaminergic cell replacement and regenerative strategies for Parkinson's disease. ACS Chem Neurosci. 2019, 10:839-51. 10.1021\/acschemneuro.8b00389","journal-title":"ACS Chem Neurosci"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2016.116","article-title":"Stem cells for modeling and therapy of Parkinson's disease","volume":"28","author":"Zhang Q","year":"2017","unstructured":"Zhang Q, Chen W, Tan S, Lin T. Stem cells for modeling and therapy of Parkinson's disease. Hum Gene Ther. 2017, 28:85-98. 10.1089\/hum.2016.116","journal-title":"Hum Gene Ther"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2005-0393","article-title":"Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation","volume":"24","author":"Brederlau A","year":"2006","unstructured":"Brederlau A, Correia AS, Anisimov SV, et al.. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells. 2006, 24:1433-40. 10.1634\/stemcells.2005-0393","journal-title":"Stem Cells"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1038\/nature23664","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model","volume":"548","author":"Kikuchi T","year":"2017","unstructured":"Kikuchi T, Morizane A, Doi D, et al.. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model. Nature. 2017, 548:592-6. 10.1038\/nature23664","journal-title":"Nature"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1093\/stmcls\/sxae042","article-title":"Advancing Parkinson's disease treatment: cell replacement therapy with neurons derived from pluripotent stem cells","volume":"42","author":"Clark BJ","year":"2024","unstructured":"Clark BJ, Lelos MJ, Loring JF. Advancing Parkinson's disease treatment: cell replacement therapy with neurons derived from pluripotent stem cells. Stem Cells. 2024, 42:781-90. 10.1093\/stmcls\/sxae042","journal-title":"Stem Cells"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-021-00238-1","article-title":"Effectiveness and mechanisms of adipose-derived stem cell therapy in animal models of Parkinson's disease: a systematic review and meta-analysis","volume":"10","author":"Li K","year":"2021","unstructured":"Li K, Li X, Shi G, et al.. Effectiveness and mechanisms of adipose-derived stem cell therapy in animal models of Parkinson's disease: a systematic review and meta-analysis. Transl Neurodegener. 2021, 10:14. 10.1186\/s40035-021-00238-1","journal-title":"Transl Neurodegener"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.09.004","article-title":"Predictive markers guide differentiation to improve graft outcome in clinical translation of hESC-based therapy for Parkinson's disease","volume":"20","author":"Kirkeby A","year":"2017","unstructured":"Kirkeby A, Nolbrant S, Tiklova K, et al.. Predictive markers guide differentiation to improve graft outcome in clinical translation of hESC-based therapy for Parkinson's disease. Cell Stem Cell. 2017, 20:135-48. 10.1016\/j.stem.2016.09.004","journal-title":"Cell Stem Cell"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.32598\/bcn.2021.1398.1","article-title":"Caffeic acid phenethyl ester with mesenchymal stem cells improves behavioral and histopathological changes in the rat model of Parkinson disease","volume":"13","author":"Rahimi JK","year":"2022","unstructured":"Rahimi JK, Safari M, Semnani V, et al.. Caffeic acid phenethyl ester with mesenchymal stem cells improves behavioral and histopathological changes in the rat model of Parkinson disease. Basic Clin Neurosci. 2022, 13:637-46. 10.32598\/bcn.2021.1398.1","journal-title":"Basic Clin Neurosci"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0507-2","article-title":"Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease","volume":"25","author":"Barker RA","year":"2019","unstructured":"Barker RA. Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease. Nat Med. 2019, 25:1045-53. 10.1038\/s41591-019-0507-2","journal-title":"Nat Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-024-00550-7","article-title":"TGF-\u03b21 mediates hypoxia-preconditioned olfactory mucosa mesenchymal stem cells improved neural functional recovery in Parkinson's disease models and patients","volume":"11","author":"Zhuo Y","year":"2024","unstructured":"Zhuo Y, Li WS, Lu W, et al.. TGF-\u03b21 mediates hypoxia-preconditioned olfactory mucosa mesenchymal stem cells improved neural functional recovery in Parkinson's disease models and patients. Mil Med Res. 2024, 11:48. 10.1186\/s40779-024-00550-7","journal-title":"Mil Med Res"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2025.01.006","article-title":"Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson's disease","volume":"32","author":"Jeon J","year":"2025","unstructured":"Jeon J, Cha Y, Hong YJ, et al.. Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson's disease. Cell Stem Cell. 2025, 32:343-360.e7. 10.1016\/j.stem.2025.01.006","journal-title":"Cell Stem Cell"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2023.2220747","article-title":"Demographic changes in a large motor neuron disease cohort in Portugal: a 27 year experience","author":"Alves I","year":"2023","unstructured":"Alves I, Gromicho M, Oliveira Santos M, Pinto S, et al.. Demographic changes in a large motor neuron disease cohort in Portugal: a 27 year experience. Amyotroph Lateral Scler Frontotemporal Degener. 2023, 1-11. 10.1080\/21678421.2023.2220747","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008620","article-title":"NurOwn, phase 2, randomized, clinical trial in patients with ALS: safety, clinical, and biomarker results","volume":"93","author":"Berry JD","year":"2019","unstructured":"Berry JD, Cudkowicz ME, Windebank AJ, et al.. NurOwn, phase 2, randomized, clinical trial in patients with ALS: safety, clinical, and biomarker results. Neurology. 2019, 93:e2294-305. 10.1212\/WNL.0000000000008620","journal-title":"Neurology"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-020-10016-7","article-title":"Umbilical cord mesenchymal stem cells in amyotrophic lateral sclerosis: an original study","volume":"16","author":"Barczewska M","year":"2020","unstructured":"Barczewska M, Maksymowicz S, Zdoli\u0144ska-Malinowska I, et al.. Umbilical cord mesenchymal stem cells in amyotrophic lateral sclerosis: an original study. Stem Cell Rev Rep. 2020, 16:922-32. 10.1007\/s12015-020-10016-7","journal-title":"Stem Cell Rev Rep"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.927484","article-title":"Repeat administration of bone marrow-derived mesenchymal stem cells for treatment of amyotrophic lateral sclerosis","volume":"26","author":"Siwek T","year":"2020","unstructured":"Siwek T, Jezierska-Wo\u017aniak K, Maksymowicz S, et al.. Repeat administration of bone marrow-derived mesenchymal stem cells for treatment of amyotrophic lateral sclerosis. Med Sci Monit. 2020, 26:e927484. 10.12659\/MSM.927484","journal-title":"Med Sci Monit"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27697","article-title":"A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis","volume":"66","author":"Cudkowicz ME","year":"2022","unstructured":"Cudkowicz ME, Lindborg SR, Goyal NA, et al.. A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis. Erratum. 2022, 66:E26-7. 10.1002\/mus.27697","journal-title":"Erratum"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01956-3","article-title":"Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1\/2a trial","volume":"28","author":"Baloh RH","year":"2022","unstructured":"Baloh RH, Johnson JP, Avalos P, et al.. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1\/2a trial. Nat Med. 2022, 28:1813-22. 10.1038\/s41591-022-01956-3","journal-title":"Nat Med"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.18-0154","article-title":"Results from phase I clinical trial with intraspinal injection of neural stem cells in amyotrophic lateral sclerosis: a long-term outcome","volume":"8","author":"Mazzini L","year":"2019","unstructured":"Mazzini L, Gelati M, Profico DC, et al.. Results from phase I clinical trial with intraspinal injection of neural stem cells in amyotrophic lateral sclerosis: a long-term outcome. Stem Cells Transl Med. 2019, 8:887-97. 10.1002\/sctm.18-0154","journal-title":"Stem Cells Transl Med"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.2174\/011574888X330199250106081717","article-title":"Evaluation of safety and efficacy of repeated mesenchymal stem cell transplantation in patients with amyotrophic lateral sclerosis (ALS) by investigating patient's specific microRNAs as novel biomarkers: a clinical trial study","author":"Alkhazaali-Ali Z","year":"2025","unstructured":"Alkhazaali-Ali Z, Sahab-Negah S, Boroumand AR, et al.. Evaluation of safety and efficacy of repeated mesenchymal stem cell transplantation in patients with amyotrophic lateral sclerosis (ALS) by investigating patient's specific microRNAs as novel biomarkers: a clinical trial study. Curr Stem Cell Res Ther. 2025, 10.2174\/011574888X330199250106081717","journal-title":"Curr Stem Cell Res Ther"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2023.04.017","article-title":"Phase 1\/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery","volume":"30","author":"Morimoto S","year":"2023","unstructured":"Morimoto S, Takahashi S, Ito D, et al.. Phase 1\/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery. Cell Stem Cell. 2023, 30:766-780.e9. 10.1016\/j.stem.2023.04.017","journal-title":"Cell Stem Cell"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac306","article-title":"Maiden voyage: induced pluripotent stem cell-based drug screening for amyotrophic lateral sclerosis","volume":"146","author":"Ito D","year":"2023","unstructured":"Ito D, Morimoto S, Takahashi S, et al.. Maiden voyage: induced pluripotent stem cell-based drug screening for amyotrophic lateral sclerosis. Brain. 2023, 146:13-9. 10.1093\/brain\/awac306","journal-title":"Brain"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.3171\/2018.12.FOCUS18602","article-title":"Stem cell therapies for acute spinal cord injury in humans: a review","volume":"46","author":"Jin MC","year":"2019","unstructured":"Jin MC, Medress ZA, Azad TD, et al.. Stem cell therapies for acute spinal cord injury in humans: a review. Neurosurg Focus. 2019, 46:E10. 10.3171\/2018.12.FOCUS18602","journal-title":"Neurosurg Focus"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02482-2","article-title":"Clinical translation of stem cell therapy for spinal cord injury still premature: results from a single-arm meta-analysis based on 62 clinical trials","volume":"20","author":"Shang Z","year":"2022","unstructured":"Shang Z, Wang M, Zhang B, et al.. Clinical translation of stem cell therapy for spinal cord injury still premature: results from a single-arm meta-analysis based on 62 clinical trials. BMC Med. 2022, 20:284. 10.1186\/s12916-022-02482-2","journal-title":"BMC Med"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48979-7","article-title":"Author Correction: Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial","volume":"15","author":"Bydon M","year":"2024","unstructured":"Bydon M, Qu W, Moinuddin FM, et al.. Author Correction: Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial. Nat Commun. 2024, 15:4799. 10.1038\/s41467-024-48979-7","journal-title":"Nat Commun"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2024.03.480","article-title":"Safety and potential efficacy of expanded mesenchymal stromal cells of bone marrow and umbilical cord origins in patients with chronic spinal cord injuries: a phase I\/II study","volume":"26","author":"Awidi A","year":"2024","unstructured":"Awidi A, Al Shudifat A, El Adwan N, et al.. Safety and potential efficacy of expanded mesenchymal stromal cells of bone marrow and umbilical cord origins in patients with chronic spinal cord injuries: a phase I\/II study. Cytotherapy. 2024, 26:825-31. 10.1016\/j.jcyt.2024.03.480","journal-title":"Cytotherapy"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1177\/09636897241298128","article-title":"Effects of combined intrathecal mesenchymal stem cells and Schwann cells transplantation on neuropathic pain in complete spinal cord injury: a phase II randomized active-controlled trial","volume":"34","author":"Akhlaghpasand M","year":"2025","unstructured":"Akhlaghpasand M, Tavanaei R, Hosseinpoor M, et al.. Effects of combined intrathecal mesenchymal stem cells and Schwann cells transplantation on neuropathic pain in complete spinal cord injury: a phase II randomized active-controlled trial. Cell Transplant. 2025, 34:9636897241298128. 10.1177\/09636897241298128","journal-title":"Cell Transplant"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2024.10.131","article-title":"Improvement of neurogenic bladder dysfunction following combined cell therapy with mesenchymal stem cell and Schwann cell in spinal cord injury: a randomized, open-label, Phase II clinical trial","volume":"194","author":"Akhlaghpasand M","year":"2025","unstructured":"Akhlaghpasand M, Tavanaei R, Allameh F, et al.. Improvement of neurogenic bladder dysfunction following combined cell therapy with mesenchymal stem cell and Schwann cell in spinal cord injury: a randomized, open-label, Phase II clinical trial. World Neurosurg. 2025, 194:123402. 10.1016\/j.wneu.2024.10.131","journal-title":"World Neurosurg"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1179\/2045772315Y.0000000048","article-title":"Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: a human trial","volume":"39","author":"Hur JW","year":"2016","unstructured":"Hur JW, Cho TH, Park DH, et al.. Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: a human trial. J Spinal Cord Med. 2016, 39:655-64. 10.1179\/2045772315Y.0000000048","journal-title":"J Spinal Cord Med"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041039","article-title":"Stem cells therapy for spinal cord injury","volume":"19","author":"Gazdic M","year":"2018","unstructured":"Gazdic M, Volarevic V, Harrell CR, et al.. Stem cells therapy for spinal cord injury. Int J Mol Sci. 2018, 19:10.3390\/ijms19041039","journal-title":"Int J Mol Sci"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8795","article-title":"A latent lineage potential in resident neural stem cells enables spinal cord repair","volume":"370","author":"Llorens-Bobadilla E","year":"2020","unstructured":"Llorens-Bobadilla E, Chell JM, Le Merre P, et al.. A latent lineage potential in resident neural stem cells enables spinal cord repair. Science. 2020, 370:10.1126\/science.abb8795","journal-title":"Science"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2014.12.004","article-title":"Safety and biodistribution study of bone marrow-derived mesenchymal stromal cells and mononuclear cells and the impact of the administration route in an intact porcine model","volume":"17","author":"M\u00e4kel\u00e4 T","year":"2015","unstructured":"M\u00e4kel\u00e4 T, Takalo R, Arvola O, et al.. Safety and biodistribution study of bone marrow-derived mesenchymal stromal cells and mononuclear cells and the impact of the administration route in an intact porcine model. Cytotherapy. 2015, 17:392-402. 10.1016\/j.jcyt.2014.12.004","journal-title":"Cytotherapy"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7649-2_31","article-title":"Intraspinal delivery of Schwann cells for spinal cord injury","volume":"1739","author":"Santamar\u00eda AJ","year":"2018","unstructured":"Santamar\u00eda AJ, Solano JP, Benavides FD, Guest JD. Intraspinal delivery of Schwann cells for spinal cord injury. Methods Mol Biol. 2018, 1739:467-84. 10.1007\/978-1-4939-7649-2_31","journal-title":"Methods Mol Biol"},{"key":"ref82","article-title":"A nerve growth factor persistent delivery scaffold seeded with neurally differentiated bone marrow mesenchymal stem cells promoted the functional recovery of spinal cord injury in rats","volume":"13","author":"Ji H","year":"2021","unstructured":"Ji H, Gu J, Song X, et al.. A nerve growth factor persistent delivery scaffold seeded with neurally differentiated bone marrow mesenchymal stem cells promoted the functional recovery of spinal cord injury in rats. Am J Transl Res. 2021, 13:2127-42.","journal-title":"Am J Transl Res"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.03.037","article-title":"Intranasal delivery of small extracellular vesicles from specific subpopulation of mesenchymal stem cells mitigates traumatic spinal cord injury","volume":"369","author":"Sun Y","year":"2024","unstructured":"Sun Y, Zhao J, Liu Q, et al.. Intranasal delivery of small extracellular vesicles from specific subpopulation of mesenchymal stem cells mitigates traumatic spinal cord injury. J Control Release. 2024, 369:335-50. 10.1016\/j.jconrel.2024.03.037","journal-title":"J Control Release"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.2174\/1574888X14666190823142911","article-title":"Human pluripotent stem cells in neurodegenerative diseases: potentials, advances and limitations","volume":"15","author":"Kolagar TA","year":"2020","unstructured":"Kolagar TA, Farzaneh M, Nikkar N, Khoshnam SE. Human pluripotent stem cells in neurodegenerative diseases: potentials, advances and limitations. Curr Stem Cell Res Ther. 2020, 15:102-10. 10.2174\/1574888X14666190823142911","journal-title":"Curr Stem Cell Res Ther"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000001609","article-title":"Recent advances in stem cell therapy: efficacy, ethics, safety concerns, and future directions focusing on neurodegenerative disorders - a review","volume":"110","author":"Khandia R","year":"2024","unstructured":"Khandia R, Gurjar P, Romashchenko V, et al.. Recent advances in stem cell therapy: efficacy, ethics, safety concerns, and future directions focusing on neurodegenerative disorders - a review. Int J Surg. 2024, 110:6367-81. 10.1097\/JS9.0000000000001609","journal-title":"Int J Surg"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020993","article-title":"Harnessing the stem cell niche in regenerative medicine: innovative avenue to combat neurodegenerative diseases","volume":"25","author":"Velikic G","year":"2024","unstructured":"Velikic G, Maric DM, Maric DL, et al.. Harnessing the stem cell niche in regenerative medicine: innovative avenue to combat neurodegenerative diseases. Int J Mol Sci. 2024, 25:10.3390\/ijms25020993","journal-title":"Int J Mol Sci"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2021.05.012","article-title":"ISSCR guidelines for stem cell research and clinical translation: the 2021 update","volume":"16","author":"Lovell-Badge R","year":"2021","unstructured":"Lovell-Badge R, Anthony E, Barker RA, et al.. ISSCR guidelines for stem cell research and clinical translation: the 2021 update. Stem Cell Reports. 2021, 16:1398-408. 10.1016\/j.stemcr.2021.05.012","journal-title":"Stem Cell Reports"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnrt.2023.100055","article-title":"Beijing declaration of International Association of Neurorestoratology (2023 Xi'an version)","volume":"11","author":"Huang H","year":"2023","unstructured":"Huang H, Chen L, Sanberg PR, et al.. Beijing declaration of International Association of Neurorestoratology (2023 Xi'an version). Jr Neur. 2023, 11:10.1016\/j.jnrt.2023.100055","journal-title":"Jr Neur"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-019-06003-3","article-title":"Stem cell\/cellular interventions in human spinal cord injury: Is it time to move from guidelines to regulations and legislations? Literature review and Spinal Cord Society position statement","volume":"28","author":"Chhabra HS","year":"2019","unstructured":"Chhabra HS, Sarda K, Jotwani G, et al.. Stem cell\/cellular interventions in human spinal cord injury: Is it time to move from guidelines to regulations and legislations? Literature review and Spinal Cord Society position statement. Eur Spine J. 2019, 28:1837-45. 10.1007\/s00586-019-06003-3","journal-title":"Eur Spine J"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00427","article-title":"Stem cell therapeutics and gene therapy for neurologic disorders","volume":"21","author":"Chen KS","year":"2024","unstructured":"Chen KS, Koubek EJ, Sakowski SA, Feldman EL. Stem cell therapeutics and gene therapy for neurologic disorders. Neurotherapeutics. 2024, 21:e00427. 10.1016\/j.neurot.2024.e00427","journal-title":"Neurotherapeutics"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-04089-1","article-title":"Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases","volume":"15","author":"Tang X","year":"2024","unstructured":"Tang X, Deng P, Li L, et al.. Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases. Stem Cell Res Ther. 2024, 15:482. 10.1186\/s13287-024-04089-1","journal-title":"Stem Cell Res Ther"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11082168","article-title":"Progress and prospects of gene editing in pluripotent stem cells","volume":"11","author":"Zhang Z","year":"2023","unstructured":"Zhang Z, Bao X, Lin CP. Progress and prospects of gene editing in pluripotent stem cells. Biomedicines. 2023, 11:10.3390\/biomedicines11082168","journal-title":"Biomedicines"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/379708-exploring-the-emerging-role-of-stem-cell-therapy-in-neurodegenerative-diseases-and-spinal-cord-injury-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T16:45:20Z","timestamp":1754671520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/379708-exploring-the-emerging-role-of-stem-cell-therapy-in-neurodegenerative-diseases-and-spinal-cord-injury-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":92,"URL":"https:\/\/doi.org\/10.7759\/cureus.89629","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}